References
- Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352: 1223-36. https://doi.org/10.1056/NEJMra041536
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
- Giudice LC. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab 2006; 20:235-44. https://doi.org/10.1016/j.beem.2006.03.005
- Iatrakis G, Tsionis C, Adonakis G, Stoikidou M, Anthouli-Anagnostopoulou F, Parava M, et al. Polycystic ovarian syndrome, insulin resistance and thickness of the endometrium. Eur J Obstet Gynecol Reprod Biol 2006;127:218-21. https://doi.org/10.1016/j.ejogrb.2006.01.023
- Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Update 2001;7:522-5. https://doi.org/10.1093/humupd/7.6.522
- Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
- Elliott JL, Hosford SL, Demopoulos RI, Perloe M, Sills ES. Endometrial adenocarcinoma and polycystic ovary syndrome: risk factors, management, and prognosis. South Med J 2001;94:529-31. https://doi.org/10.1097/00007611-200105000-00020
- Cheung AP. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome. Obstet Gynecol 2001;98:325-31. https://doi.org/10.1016/S0029-7844(01)01432-6
- Sakamoto C. Sonographic criteria of phasic changes in human endometrial tissue. Int J Gynaecol Obstet 1985;23:7-12. https://doi.org/10.1016/0020-7292(85)90003-7
- Daniilidis A, Dinas K. Long term health consequences of polycystic ovarian syndrome: a review analysis. Hippokratia 2009;13:90-2.
- Montgomery BE, Daum GS, Dunton CJ. Endometrial hyperplasia: a review. Obstet Gynecol Surv 2004;59:368-78. https://doi.org/10.1097/00006254-200405000-00025
- Wild S, Pierpoint T, Jacobs H, McKeigue P. Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil (Camb) 2000;3:101-5. https://doi.org/10.1080/1464727002000198781
- Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983;61:403-7.
- Dubinsky TJ. Value of sonography in the diagnosis of abnormal vaginal bleeding. J Clin Ultrasound 2004;32:348-53. https://doi.org/10.1002/jcu.20049
- Goldstein SR. The role of transvaginal ultrasound or endometrial biopsy in the evaluation of the menopausal endometrium. Am J Obstet Gynecol 2009;201:5-11. https://doi.org/10.1016/j.ajog.2009.02.006
- Pillay OC, Te Fong LF, Crow JC, Benjamin E, Mould T, Atiomo W, et al. The association between polycystic ovaries and endometrial cancer. Hum Reprod 2006;21:924-9. https://doi.org/10.1093/humrep/dei420
Cited by
- Estrogen receptor β: the guardian of the endometrium vol.21, pp.2, 2015, https://doi.org/10.1093/humupd/dmu053
- The evaluation of endometrial sulfate glycosaminoglycans in women with polycystic ovary syndrome vol.31, pp.4, 2015, https://doi.org/10.3109/09513590.2014.989980
- Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia vol.22, pp.6, 2011, https://doi.org/10.1177/1933719114561553
- Hormones and endometrial carcinogenesis vol.25, pp.2, 2011, https://doi.org/10.1515/hmbci-2016-0005
- Pathophysiology of Heavy Menstrual Bleeding vol.12, pp.1, 2011, https://doi.org/10.2217/whe.15.81
- Current strategies in the diagnosis of endometrial cancer vol.296, pp.1, 2011, https://doi.org/10.1007/s00404-017-4391-z
- Endometrial Thickness as a Predictor of Endometrial Hyperplasia in Infertile Patients with Polycystic Ovary Syndrome vol.8, pp.2, 2018, https://doi.org/10.4236/ojog.2018.82012
- Combined estrogen-progestin pill is a safe and effective option for endometrial hyperplasia without atypia: a three-year single center experience vol.30, pp.3, 2011, https://doi.org/10.3802/jgo.2019.30.e49
- Treatment with metformin and sorafenib alleviates endometrial hyperplasia in polycystic ovary syndrome by promoting apoptosis via synergically regulating autophagy vol.235, pp.2, 2020, https://doi.org/10.1002/jcp.29051
- High level of visfatin and the activation of Akt and ERK1/2 signaling pathways are associated with endometrium malignant transformation in polycystic ovary syndrome vol.36, pp.2, 2011, https://doi.org/10.1080/09513590.2019.1650340
- Potential of Auraptene in Improvement of Oocyte Maturation, Fertilization Rate, and Inflammation in Polycystic Ovary Syndrome Mouse Model vol.27, pp.9, 2011, https://doi.org/10.1007/s43032-020-00168-9
- Endometrial cancer combined with polycystic ovary syndrome in 9 women under 40-years old: A case report vol.13, pp.5, 2011, https://doi.org/10.3892/br.2020.1357
- Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women With Polycystic Ovary Syndrome vol.12, pp.None, 2011, https://doi.org/10.3389/fendo.2021.614679
- Endometrial hyperplasia: without atypia and with atypia vol.23, pp.1, 2011, https://doi.org/10.26442/20795696.2021.1.200666
- Prevention of endometrial hyperplasia without atypia in women of reproductive age vol.23, pp.5, 2011, https://doi.org/10.26442/20795696.2021.5.201217